IHS Chemical Week

Regions :: Western Europe :: Germany

Bayer enters into cancer immunotherapy collaboration with Compugen

4:41 AM MDT | August 5, 2013 | Deepti Ramesh

Bayer says that its Bayer HealthCare subgroup has entered into an oncology collaboration and license agreement with drug discovery company Compugen (Tel Aviv, Israel). The partnership will focus on the research, development, and commercialization of antibody-based therapeutics for cancer immunotherapy against two novel immune checkpoint regulators discovered by Compugen. Bayer and Compugen, under the agreement, will jointly pursue a preclinical research program; Bayer will have full control over further development and worldwide commercialization rights for...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa